Safety and Efficacy of Propranolol for the Treatment of Familial Cerebral Cavernous Malformations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
Lancet Neurol 2022 Nov 17;[EPub Ahead of Print], S Lanfranconi, E Scola, JMTA Meessen, R Pallini, GA Bertani, R Al-Shahi Salman, E Dejana, R LatiniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.